Association between polygenic risk for Alzheimer's disease, brain structure and cognitive abilities in UK Biobank.


Journal

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907

Informations de publication

Date de publication:
01 2022
Historique:
received: 19 03 2021
accepted: 14 09 2021
revised: 05 08 2021
pubmed: 9 10 2021
medline: 3 3 2022
entrez: 8 10 2021
Statut: ppublish

Résumé

Previous studies testing associations between polygenic risk for late-onset Alzheimer's disease (LOAD-PGR) and brain magnetic resonance imaging (MRI) measures have been limited by small samples and inconsistent consideration of potential confounders. This study investigates whether higher LOAD-PGR is associated with differences in structural brain imaging and cognitive values in a relatively large sample of non-demented, generally healthy adults (UK Biobank). Summary statistics were used to create PGR scores for n = 32,790 participants using LDpred. Outcomes included 12 structural MRI volumes and 6 concurrent cognitive measures. Models were adjusted for age, sex, body mass index, genotyping chip, 8 genetic principal components, lifetime smoking, apolipoprotein (APOE) e4 genotype and socioeconomic deprivation. We tested for statistical interactions between APOE e4 allele dose and LOAD-PGR vs. all outcomes. In fully adjusted models, LOAD-PGR was associated with worse fluid intelligence (standardised beta [β] = -0.080 per LOAD-PGR standard deviation, p = 0.002), matrix completion (β = -0.102, p = 0.003), smaller left hippocampal total (β = -0.118, p = 0.002) and body (β = -0.069, p = 0.002) volumes, but not other hippocampal subdivisions. There were no significant APOE x LOAD-PGR score interactions for any outcomes in fully adjusted models. This is the largest study to date investigating LOAD-PGR and non-demented structural brain MRI and cognition phenotypes. LOAD-PGR was associated with smaller hippocampal volumes and aspects of cognitive ability in healthy adults and could supplement APOE status in risk stratification of cognitive impairment/LOAD.

Identifiants

pubmed: 34621014
doi: 10.1038/s41386-021-01190-4
pii: 10.1038/s41386-021-01190-4
pmc: PMC8674313
doi:

Substances chimiques

Apolipoprotein E4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

564-569

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003403/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

Transl Psychiatry. 2018 May 18;8(1):99
pubmed: 29777097
Clin Epidemiol. 2018 Aug 08;10:949-960
pubmed: 30123007
Mol Psychiatry. 2012 Oct;17(10):1026-30
pubmed: 22614288
Neurobiol Aging. 2016 Apr;40:68-77
pubmed: 26973105
PLoS One. 2020 Apr 20;15(4):e0231627
pubmed: 32310977
Nat Genet. 2019 Mar;51(3):414-430
pubmed: 30820047
Am J Hum Genet. 2015 Oct 1;97(4):576-92
pubmed: 26430803
BMC Med. 2014 Nov 11;12:206
pubmed: 25385447
Neurotherapeutics. 2017 Jan;14(1):35-53
pubmed: 27738903
Neuron. 2009 Aug 13;63(3):287-303
pubmed: 19679070
J Hypertens. 2020 Dec;38(12):2482-2489
pubmed: 32665523
PLoS One. 2016 Apr 25;11(4):e0154222
pubmed: 27110937
Nat Rev Neurosci. 2003 Jan;4(1):37-48
pubmed: 12511860
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Nov;2(8):673-679
pubmed: 29560901
Brain Imaging Behav. 2020 Oct;14(5):1468-1476
pubmed: 30903549
Eur Heart J. 2017 Feb 21;38(8):577-583
pubmed: 28363219
Nature. 2021 Mar;591(7849):211-219
pubmed: 33692554
Clin Nurs Res. 2021 Jan;30(1):59-69
pubmed: 30943786
J Alzheimers Dis. 2017;57(1):275-283
pubmed: 28222519
Sci Rep. 2016 Feb 15;6:20873
pubmed: 26876151
Nat Rev Neurol. 2018 Jul;14(7):399-415
pubmed: 29895964
Neurology. 2016 Aug 2;87(5):481-8
pubmed: 27385740
Am J Hum Genet. 2016 Nov 3;99(5):1130-1139
pubmed: 27773431
Stroke. 2020 Jul;51(7):2111-2121
pubmed: 32517579
Neurobiol Aging. 2013 Dec;34(12):2726-33
pubmed: 23850342
Ann N Y Acad Sci. 2007 Feb;1097:183-214
pubmed: 17413023
J Neurosci. 2003 Feb 1;23(3):994-1005
pubmed: 12574429
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372

Auteurs

Rachana Tank (R)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Joey Ward (J)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Kristin E Flegal (KE)

Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK.

Daniel J Smith (DJ)

Centre for Clinical Brain Sciences, Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Mark E S Bailey (MES)

School of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Jonathan Cavanagh (J)

Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK.

Donald M Lyall (DM)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK. Donald.Lyall@Glasgow.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH